Biblio

Author Title [ Type

] Year

Filters: Author is Alati, Caterina [Clear All Filters]

Journal Article

Martino M, Canale FAntonio, Porto G, Verduci C, Utano G, Policastro G, Germanò J, Alati C, Santoro L, Imbalzano L, et al. Integrating CAR-T cell therapy into the management of DLBCL: what we are learning. Expert Opin Biol Ther. 2023:1-9.

Martino M, Gori M, Porto G, Pellicano M, Santoro L, Verduci C, Canale FAntonio, Loteta B, Moscato T, Alati C, et al. Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation. Ann Hematol. 2023.

Cardinali D, Beldinanzi M, Ansuinelli M, Elia L, Starza IDella, Bellomarino V, Matarazzo M, Di Trani M, Cola M, Salutari P, et al. Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase. Leuk Lymphoma. 2023:1-4.

Martino M, Gori M, Porto G, Pellicano M, Santoro L, Verduci C, Canale FAntonio, Loteta B, Moscato T, Alati C, et al. Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation. Ann Hematol. 2023.

Canale FAntonio, Pitea M, Alati C, Porto G, Pratico G, Utano G, Germanò J, Imbalzano L, Ferreri A, Verduci C, et al. Case Report: CAR-T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantation. Eur J Haematol. 2023.